- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05680779
Neuromodulation in Chronic Ankle Instability
Ultrasound-guided Percutaneous Neuromodulation in Patiens With Chronic Ankle Instability
Ankle sprain is a common injury. Around 712,000 sprains occur every day in the world. It is estimated that they account for 45% of sports injuries, being the second part of the body that is most frequently injured in sports. Of the patients who suffer this injury, around 70% will develop chronic ankle instability, a situation that can cause residual pain, recurrent sprains, a feeling of lack of stability and decreased physical activity.
Two entities can be included in chronic ankle instability: mechanical instability, which involves movement of the joint beyond its physiological limit, and functional instability, which includes proprioceptive dysfunction, impaired neuromuscular control, postural control, and strength deficits.
Currently, the conservative treatment of these patients consists of neuromuscular training through the use of dynamic balance platforms, taping, joint mobilization, dry needling, and the use of plantar supports, balance training being the one that has shown the best result.
Ultrasound-guided percutaneous neuromodulation (PNM) is a recently used technique in the field of invasive physiotherapy that consists of applying a square wave biphasic electrical current through an acupuncture needle-like electrode that is place in close proximity to the nerve with ultrasound guidance. The aim of this study is to evaluate the effectiveness of PNM in ankle instability.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Madrid
-
Alcalá de Henares, Madrid, Spain, 28805
- Physioterapy and Pain center research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ankle instability
Exclusion Criteria:
- Subjects taking NSAIDs, analgesics or muscle relaxants
- Epilepsy
- Belonephobia or allergy to metals
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PNM group
Subjects were treated once time.
The technique consisted in the application of a square wave biphasic electrical current, with 10 Hz frequency, with 250 μs pulse width and the maximal torelable intensity to cause an exacerbated muscle contraction during ten seconds with a rest period of another ten seconds y total number of ten times.
The subjects were lying in lateral decubitus.
The common peroneal nerve was located with ultrasound (cross section) near to the peroneal head.
After, an acupuncture needle (0,30mm x 30mm) was inserted in a long axis approach until the perineurium of the common peroneal nerve (in close proximity)
|
It´s an intervention of physiotherapy
|
|
Other: Control group
Subjects were treated once time.
The subjects were lying in lateral decubitus.
The common peroneal nerve was located with ultrasound (cross section) near to the peroneal head.
After, an acupuncture needle (0,30mm x 30mm) was inserted in a long axis approach until the perineurium of the common peroneal nerve (in close proximity).
The needle remains in this location during 200 seconds without any electrical current.
|
It´s an intervention of physiotherapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cumberland ankle instability tool
Time Frame: Change from Baseline up to three months
|
The Cumberland ankle instability tool (CAIT) is a questionnaire that consists of 9 items, the maximum score of the questionnaire is 30 points, the lower the score obtained, the more severe the functional instability of the ankle.
The Spanish version of the CAIT has high internal consistency (Cronbach's α00.766) and reliability (intraclass correlation coefficient 0.979, 95 % confidence interval (CI) 0.958-0.990).
|
Change from Baseline up to three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Byodex Balance System (BBS)
Time Frame: Change from Baseline up to 5 minutes
|
The BBS is a platform designed to measure and record an individual´s ability to maintain stability under dynamic stress.
It calculates a medial-lateral stability index (MLSI), anterior-posterior stability index (APSI), and an overall stability index (OSI) with reliability estimates of R= 0.92 (OSI), R = 0.89 (APSI), R= 0.93 (MLSI).
|
Change from Baseline up to 5 minutes
|
|
Electromyography muscle (EMG)
Time Frame: Change from Baseline up to 5 minutes
|
Mdurance EMG system is valid tool to measure muscle activity during isokinetic contractions.
It has shown an almost perfect Intraclass Correlation Coefficient>0.81.
|
Change from Baseline up to 5 minutes
|
|
stiffness tissue
Time Frame: Change from Baseline up to 5 minutes
|
Myoton Pro is a device designed to measure and record Oscillation frequency (pitch), dynamic stiffness (stiffness), logarithmic decrement (elasticity), mechanical stress relaxation time and creep.
It has shown an excellent reliability, Intraclass Correlation Coefficient 0.91-0.96 in all measures with the exception of elasticity 0.78-0.86
|
Change from Baseline up to 5 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Daniel Pecos-Martin, PhD, Alcala University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEID/2022/2/031
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Sprains
-
Riphah International UniversityRecruiting
-
Riphah International UniversityRecruitingAnkle SprainsPakistan
-
MEDRx USA, Inc.CompletedAnkle SprainsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting
-
Superior UniversityActive, not recruiting
-
Taipei Medical University WanFang HospitalCompleted
-
Lazaros LazarouCompletedAnkle SprainsGreece
-
Rehabilitation Centre ZivotCompletedAnkle SprainsBosnia and Herzegovina
-
Universiteit AntwerpenUniversity Hospital, Antwerp; University of Ulster; Bern University of Applied...Recruiting
-
Riphah International UniversityCompleted
Clinical Trials on ultrasound-guided percutaneous neuromodulation
-
Jose Antonio Garcia VidalUniversidad de MurciaCompleted
-
Clinica Francisco Ortega Rehabilitacion Avanzada...Completed
-
University of AlcalaNot yet recruiting
-
Universidad Europea de MadridCompleted
-
Blanca de la Cruz TorresCompleted
-
Alejandro Martín GarcíaRecruitingGait Disorders, Neurologic | IctusSpain
-
University of AlcalaCompleted
-
University of California, San DiegoCopenhagen University Hospital at Herlev; University California Academic Senate and other collaboratorsCompletedPostoperative PainUnited States
-
Universidad de ZaragozaAragon Institute for Health Research (IIS Aragón)CompletedShoulder Pain Syndrome | Nonspecific Shoulder PainSpain
-
Chinese PLA General HospitalActive, not recruitingAblation | Benign Thyroid NodulesChina